The 2014 plastic-surgery statistics will be released later
today by the American Society for Aesthetic Plastic Surgery (ASAPS). Thanks to
an advance peek, I can report that butts are getting bigger, while breasts are
getting smaller.
Buttock augmentations are up 86 percent over 2013. Michael
C. Edwards, a plastic surgeon and the president of the ASAPS notes that most
women don’t want giant backsides, they just want more shapely ones. The other
big news is breast revisions, which are up 30.4 percent. Many attribute that
rise to aging implants in need of replacement, along with many women’s desire
to switch from saline to silicone-gel-filled implants, which may not have been
available when they originally had surgery. What’s more, insiders say most of
these women are exchanging their old implants for smaller replacements.
The other news in the numbers is a five percent drop in
overall procedures: 10,663,607 in 2014, down from 11,419,610 in 2013. The
decrease was mostly in minimally-invasive procedures like Botox and fillers. No
explanation for this was offered by the ASAPS, but could it be what I call
injection fatigue? Many women I’ve spoken to don’t want to return again and
again for refills. Surgical procedures fell only 1.5 percent from 1,883,048 to
1,764,956, a drop that the number crunchers say is not statistically
significant.
Fat—and getting rid of it—is still a high priority. In
recent years the top surgical procedures for women have flipped back and forth
between breast implants and liposuction. In 2014, liposuction held the number
one spot, followed by breast augmentation (down 8.5 percent), tummy tuck,
blepharoplasty (or eye lift), and in fifth place, the breast lift. Facelifts
are in eighth place.
Liposuction may still be king (or is it queen?) in the
surgical department, but non-surgical fat reduction with devices such as
CoolSculpting and VASERshape rose a whopping 42.7 percent, from 94,922 in 2013
to 135,448 in 2014. That number could rise even more this year if ATX-101, an
injection for fat reduction under the chin, gets FDA clearance, which it’s
expected to receive.
No comments:
Post a Comment